Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity

Disease and Therapeutics · Elsevier

Аннотация

Publication date: Available online 6 November 2026 Source: Disease and Therapeutics Author(s): Jarrett J. Adams, Yun Hye Kim, Kris Barreto, Wendy Bernhard, Kate Muzalevska, Andres Medina Salguero, Craig A. Hokanson, Valeria Castano, Ryan Liang, Nick Jarvik, Chao Chen, Maryna Gorelik, Lynda Ploder, Julia Garcia, Isabelle Pot, C. Ronald Geyer, Stephane Angers, Sachdev S. Sidhu

Читать у издателя →

Похожие статьи